The Journal of the American Dental Association
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Am Dent Assoc, Vol 140, No 1, 80-84.
© 2009 American Dental Association

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Menezes, R.
Right arrow Articles by Vieira, A. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Menezes, R.
Right arrow Articles by Vieira, A. R.

RESEARCH

AXIS inhibition protein 2, orofacial clefts and a family history of cancer



Renato Menezes, DDS, MS, PhD, Mary Louise Marazita, PhD, Toby Goldstein McHenry, BS, Margaret E. Cooper, MSIS, MEd, MS, Kathleen Bardi, BS, Carla Brandon, MS, Ariadne Letra, DDS, MS, PhD, Rick A. Martin, PhD and Alexandre Rezende Vieira, DDS, MS, PhD

Background. Cancer and congenital malformations occasionally may have acommon etiology. The authors investigated whether families with one or more members affected by orofacial clefts (that is, families segregating orofacial clefts) had an increased cancer incidence when compared with control families.

Methods. The authors assessed 75 white families with nonsyndromic cleft lip with or without cleft palate (CL/P) and 93 white control families regarding a history of cancer. They used {chi}2 and Fisher exact tests to determine significant differences. They then performed molecular studies with genes in which mutations have been independently associated with both cancer and craniofacial anomalies in a total of 111 families with CL/P.

Results. The families with CL/P reported a family history of cancer more often than did control families (P <.001), and they had higher rates of specific cancer types: colon (P <.001), brain (P = .003), leukemia (P = .005), breast (P = .009), prostate (P = .01), skin (P = .01), lung (P = .02) and liver (P = .02). The authors detected overtransmission of AXIS inhibition protein 2 (AXIN2) in CL/P probands (P = .003).

Conclusion. Families segregating CL/P may have an increased susceptibility to cancer, notably colon cancer. Furthermore, AXIN2, a gene that when mutated increases susceptibility to colon cancer, also is associated with CL/P.

Clinical Implications. People who are at a higher risk of developing disease need to adopt a healthier lifestyle, including avoiding exposure to risk factors that may interact with their genotypes.

Key Words: Orofacial clefts; family history of cancer; AXIN2

Abbreviations: AXIN2: AXIS inhibition protein 2. • CDH1: Epithelial cadherin. • CL/P: Cleft lip with or without cleft palate. • FBAT: Family based association test. • FGF: Fibroblast growth factor. • FGFR: FGF receptor. • IRB: Institutional review board. • SNP: Single nucleotide polymorphism. • 3'UTR: Three prime untranslated region.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright©1995-2009 American Dental Association (ADA).
Reproduction or republication strictly prohibited without prior written permission of ADA.